Pfizer Enters Generic Drug Market Via The Launch Of Six Drugs

Multinational drugmaker Pfizer has entered the UK's GBP4.74bn (US$7.30bn) generic drug market. The company has launched six off-patented drugs through its Established Products Business Unit's agreement with Indian drugmakers Aurobindo Pharma and Claris

To read the full article, please choose one of the following options: